Sai Parenteral IPO Day 2: GMP trends, subscribed only 4% so far. Should you subscribe?

+12.4

Market Impact Score

-100 Bearish+100 Bullish

AI Analysis

The broader IPO market in India can be sensitive to initial subscription numbers, with strong early demand often signaling a successful listing. A slow start for an IPO can reflect investor caution or concerns about valuation and future prospects.

Trading Insight

For IPOs with weak initial subscription, a 'wait and watch' approach is advisable, focusing on final subscription figures and GMP before considering any pre-listing or listing day trades.

Quick check: TATASTEEL neutral (+2.3% 1d), HINDALCO bearish bias (+1.4% 1d).

Key Evidence

•Sai Parenteral Limited's IPO is on its second day of bidding.
•The IPO had a slow start on its first day.
•The company aims to raise Rs 409 crore.
•The subscription window closes on Friday, March 27.
•The IPO is subscribed only 4% so far on Day 2.

Affected Stocks

Sai Parenteral Limited

Negative

Low subscription rate on Day 2 indicates weak investor demand, potentially leading to a subdued listing.

AI-powered analysis by

Anadi Algo News